May 13 - 15, 2019 | Las Vegas

Emerald Health Therapeutics

Booth: 114

Emerald is focused on the development of pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the endocannabinoid system. The near-term investment opportunities within our portfolio are: Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF), a Licensed Producer of cannabis for medical and recreational purposes; Nemus Bioscience (OTCQB: NMUS), a biopharmaceutical company developing cannabinoid-based therapeutics; and Emerald Health Pharmaceuticals, a pre-IPO biopharmaceutical company developing treatments for autoimmune diseases.